Biocon Biologics and Civica Join Forces to Enhance Insulin Aspart Access in the U.S. The collaboration between Biocon Biologics and Civica, Inc. is set to improve the accessibility and affordability of Insulin Aspart in the United States, addressing significant diabetes care needs.

Biocon Biologics and Civica Join Forces to Enhance Insulin Aspart Access in the U.S. #United_States #Virginia #Biocon #Civica #Insulin_Aspart